Correlation Between Pfizer and Intermap Technologies

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and Intermap Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Intermap Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc CDR and Intermap Technologies Corp, you can compare the effects of market volatilities on Pfizer and Intermap Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Intermap Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Intermap Technologies.

Diversification Opportunities for Pfizer and Intermap Technologies

-0.74
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Pfizer and Intermap is -0.74. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc CDR and Intermap Technologies Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Intermap Technologies and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc CDR are associated (or correlated) with Intermap Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Intermap Technologies has no effect on the direction of Pfizer i.e., Pfizer and Intermap Technologies go up and down completely randomly.

Pair Corralation between Pfizer and Intermap Technologies

Assuming the 90 days trading horizon Pfizer Inc CDR is expected to under-perform the Intermap Technologies. But the stock apears to be less risky and, when comparing its historical volatility, Pfizer Inc CDR is 3.75 times less risky than Intermap Technologies. The stock trades about -0.05 of its potential returns per unit of risk. The Intermap Technologies Corp is currently generating about 0.18 of returns per unit of risk over similar time horizon. If you would invest  57.00  in Intermap Technologies Corp on August 30, 2024 and sell it today you would earn a total of  100.00  from holding Intermap Technologies Corp or generate 175.44% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Pfizer Inc CDR  vs.  Intermap Technologies Corp

 Performance 
       Timeline  
Pfizer Inc CDR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc CDR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.
Intermap Technologies 

Risk-Adjusted Performance

18 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Intermap Technologies Corp are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Intermap Technologies displayed solid returns over the last few months and may actually be approaching a breakup point.

Pfizer and Intermap Technologies Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and Intermap Technologies

The main advantage of trading using opposite Pfizer and Intermap Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Intermap Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Intermap Technologies will offset losses from the drop in Intermap Technologies' long position.
The idea behind Pfizer Inc CDR and Intermap Technologies Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Complementary Tools

Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Money Managers
Screen money managers from public funds and ETFs managed around the world
Transaction History
View history of all your transactions and understand their impact on performance
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum